How to Buy Acadia Pharmaceuticals Inc. (ACAD) Stock

Where to buy ACAD

13 brokers in our matrix offer ACAD. Verify availability and current fees with each broker before trading.

Broker	Commission	Fractional	Extended	Overnight	Options	OTC access
Charles Schwab (thinkorswim)	$0	Schwab Stock Slices, S&P 500 only, ≥ $5/slice, up to 30 at once		~1,130	$0.65	Most (3/5)
E*TRADE (Morgan Stanley)	$0 listed			~20	$0.65	Most (4/5)
Fidelity	$0	Stocks by the Slice, 7,000+ stocks/ETFs, from $1			$0.65	Partial (2+0)
Firstrade	$0	~4,000+ tickers, ≥ $5		~1,200	$0	Most (4/5)
Interactive Brokers	$0 (Lite) / per-share (Pro)			~10,000	per-contract pricing	Full
Merrill Edge	$0				$0.65	Most (3/5)
Moomoo	$0				$0	Limited only
Public.com	$0				rebate model	Limited only
Robinhood	$0	≥ $1 stocks, market cap ≥ $25M		~1,134	$0	None
SoFi Active Investing	$0				$0	Partial (1+2)
tastytrade	$0 stocks				$1.00 open, $0 close (capped at $10 per leg)	Limited only
TradeStation	$0 listed				$0.50 / $0.60	Most (4/5)
Webull	$0				$0	Limited only

24-Hour / Overnight trading

ACAD may be eligible for overnight trading via Charles Schwab (thinkorswim), Interactive Brokers, Robinhood, E*TRADE (Morgan Stanley), Webull, Moomoo, Firstrade. Each broker maintains its own eligibility list — confirm before placing an order.

About Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on turning scientific promise to makes a difference for underserved neurological and rare disease communities around the world. It has two core franchises in neurological and rare diseases. Its neurological disease is anchored by the commercial product NUPLAZID (pimavanserin), which is the first and only drug approved by the U.S. (FDA) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis (PDP). Its rare disease is anchored by the commercial product DAYBUE, which is the first and only drug approved for the treatment of Rett syndrome. Its clinical-stage development efforts are focused on Alzheimer's disease psychosis, Lewy Body Dementia psychosis, and multiple other programs.

Sector

PHARMACEUTICAL PREPARATIONS

Employees

798

Headquarters

SAN DIEGO, CA

Listed

2004-05-27

Market cap

$3.72B

Frequently asked

Where can I buy Acadia Pharmaceuticals Inc. (ACAD)?

ACAD is offered by 13 brokers in our matrix, including Charles Schwab (thinkorswim), E*TRADE (Morgan Stanley), Fidelity, Firstrade, Interactive Brokers. Compare commissions, fractional eligibility, and overnight availability in the broker matrix above.

Can I buy ACAD after hours or overnight?

Yes. ACAD is on the 24-hour eligibility list for Charles Schwab (thinkorswim), Interactive Brokers, Robinhood, E*TRADE (Morgan Stanley), and others. Overnight sessions route through ATSs with wider spreads and limit-orders only.

Does Robinhood offer ACAD?

Yes. Robinhood offers ACAD as a regular exchange-listed security.

Does Fidelity offer ACAD?

Yes. Fidelity offers ACAD as a regular exchange-listed security.

Does Webull offer ACAD?

Yes. Webull offers ACAD as a regular exchange-listed security.

Is ACAD optionable?

Yes. ACAD has listed options contracts. Per-contract pricing varies by broker — see the Options column in the matrix.

Is there a tokenized version of ACAD?

Not in our current dataset. The tokenized stock universe (Kraken xStocks, Binance Alpha/Ondo, Robinhood EU, Hyperliquid HIP-3) is expanding quickly — we refresh quarterly.

Can I buy a fractional share of ACAD?

Yes. Multiple brokers in the matrix support fractional shares for ACAD — see the Fractional column above for per-broker eligibility and minimums.